Tiziana Life Sciences Ltd (TLSA) is currently trading at $1.18 with a Wall Street consensus price target of $8.99, implying potential upside of 661.7% over the next 12 months. 1 analysts currently cover TLSA, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.99, while the most cautious has a target of $8.99.
TLSA operates in the Healthcare sector with a market capitalisation of $150M. The stock is down 26.3% year-to-date and is currently trading near the lower end of its 52-week range of $1.04 – $2.6.
Other Healthcare stocks with comparable size and valuation.
Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.
Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.
StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.
View Full Rankings →